Literature DB >> 6799507

Swainsonine prevents the processing of the oligosaccharide chains of influenza virus hemagglutinin.

A D Elbein, P R Dorling, K Vosbeck, M Horisberger.   

Abstract

Swainsonine, an indolizidine alkaloid, inhibits the alpha-mannosidase that is involved in glycoprotein processing. Thus, in cultured animal cells, this alkaloid causes an increase in the surface content of high mannose glycoproteins and a decrease in the amount of complex type glycoproteins (Elbein, A. D., Solf, R., Dorling, P. R., and Vosbeck, K. (1982) Proc. Natl. Acad. Sci. U. S. A., 78, 7393-7397). In this report, the effect of swainsonine on the synthesis virus hemagglutinins was examined. Primary calf kidney cultures were infected with influenza virus and viral replication was allowed to proceed in the absence or presence of swainsonine. Several hours after the addition of swainsonine, [2-3H]mannose or [6-3H]glucosamine were added to label the hemagglutinins and the mature virus particles were isolated. Virus particles raised in the presence of this alkaloid had the same infectivity and hemagglutination titer as virus particles from control cells. However, when the hemagglutinins were examined on sodium dodecyl sulfate gels, the major hemagglutinin (HA0) and its subunits, HA1 and HA2, from swainsonine-treated cells, migrated faster, indicating that they were of lower molecular weights. The labeled hemagglutinins were digested with pronase and the resulting glycopeptides were chromatographed on Bio-Gel P-4. Both the mannose-labeled and glucosamine-labeled glycopeptides from swainsonine-treated virus migrated more slowly on these columns than those of controls cells, suggesting that they were altered in structure. Furthermore, when the glycopeptides were digested with endoglucosaminidase H, 90% of the glycopeptides from swainsonine-treated cells were susceptible to this enzyme, whereas only 30% of those from control cells were digested. The major oligosaccharide released from inhibited cells by endoglucosaminidase H was digestible with alpha-mannosidase, whereas that of control cells was resistant to this enzyme. However, the control cell glycopeptide was digested by a combination of neuraminidase, beta-galactosidase, beta-N-acetylhexosaminidase, and alpha-mannosidase. These data show that swainsonine prevents the formation of complex glycoproteins and gives rise to increased amounts of high-mannose glycoproteins.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6799507

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Comparative study of the glycosylation of platelet glycoprotein GPIIb/IIIa and the vitronectin receptor. Differential processing of their beta-subunit.

Authors:  A Troesch; A Duperray; B Polack; G Marguerie
Journal:  Biochem J       Date:  1990-05-15       Impact factor: 3.857

2.  Properties of baby-hamster kidney (BHK) cells treated with Swainsonine, an inhibitor of glycoprotein processing. Comparison with ricin-resistant BHK-cell mutants.

Authors:  L Foddy; J Feeney; R C Hughes
Journal:  Biochem J       Date:  1986-02-01       Impact factor: 3.857

3.  Mechanism of Inhibition of Jack Bean alpha-Mannosidase by Swainsonine.

Authors:  M S Kang; A D Elbein
Journal:  Plant Physiol       Date:  1983-03       Impact factor: 8.340

4.  Assembly and processing of the disulfide-linked varicella-zoster virus glycoprotein gpII(140).

Authors:  E A Montalvo; C Grose
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

5.  The Saccharomyces cerevisiae DPM1 gene encoding dolichol-phosphate-mannose synthase is able to complement a glycosylation-defective mammalian cell line.

Authors:  P J Beck; P Orlean; C Albright; P W Robbins; M J Gething; J F Sambrook
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

6.  Processing of the glycoprotein of feline immunodeficiency virus: effect of inhibitors of glycosylation.

Authors:  E B Stephens; E Monck; K Reppas; E J Butfiloski
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

7.  Alterations in the structure of the oligosaccharide of vesicular stomatitis virus G protein by swainsonine.

Authors:  M S Kang; A D Elbein
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

8.  The storage products in genetic and swainsonine-induced human mannosidosis.

Authors:  I Cenci di Bello; P Dorling; B Winchester
Journal:  Biochem J       Date:  1983-12-01       Impact factor: 3.857

9.  Inhibitors of glycoprotein processing alter T-cell proliferative responses to antigen and to interleukin 2.

Authors:  K A Wall; J D Pierce; A D Elbein
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

10.  Proteins of the kidney microvillar membrane. Effects of monensin, vinblastine, swainsonine and glucosamine on the processing and assembly of endopeptidase-24.11 and dipeptidyl peptidase IV in pig kidney slices.

Authors:  J R Stewart; A J Kenny
Journal:  Biochem J       Date:  1984-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.